People with diabetes and others taking glucagon-like peptide-1 receptor agonists (GLP-1RAs) should be monitored for nutritional deficiencies and muscle loss, researchers said. "We found that adults ...
Adults with overweight or obesity taking the new generation of weight loss drugs semaglutide and tirzepatide tend to eat significantly less, leaving them vulnerable to nutritional deficiencies, ...
Samsung and Mass General are studying whether Galaxy Watch8 data can help doctors monitor muscle loss during GLP-1 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results